Eszter Csomor

768 total citations
15 papers, 518 citations indexed

About

Eszter Csomor is a scholar working on Immunology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Eszter Csomor has authored 15 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Pathology and Forensic Medicine and 3 papers in Dermatology. Recurrent topics in Eszter Csomor's work include Systemic Sclerosis and Related Diseases (5 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). Eszter Csomor is often cited by papers focused on Systemic Sclerosis and Related Diseases (5 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). Eszter Csomor collaborates with scholars based in United Kingdom, United States and Netherlands. Eszter Csomor's co-authors include Zsuzsa Bajtay, Anna Erdei, Noémi Sándor, Koloman Krištof, Stefan Nierkens, Tomas Mustelin, Ian Strickland, Julia Drylewicz, Barbara Giovannone and Matthew A. Sleeman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Eszter Csomor

15 papers receiving 511 citations

Peers

Countries citing papers authored by Eszter Csomor

Since Specialization

Citations

This map shows the geographic impact of Eszter Csomor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eszter Csomor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eszter Csomor more than expected).

Fields of papers citing papers by Eszter Csomor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eszter Csomor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eszter Csomor. The network helps show where Eszter Csomor may publish in the future.

Co-authorship network of co-authors of Eszter Csomor

This figure shows the co-authorship network connecting the top 25 collaborators of Eszter Csomor. A scholar is included among the top collaborators of Eszter Csomor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eszter Csomor. Eszter Csomor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Epithelial Interleukin‐1 Receptor‐Like‐1 Activation Is Contingent on Interleukin‐33 Isoforms and Asthma‐Related Receptor Variation 2024 ·Clinical & Experimental Allergy ·Michael A. Portelli, Maria E. Ketelaar, Stewart Bates, Eszter Csomor, Dominick Shaw, Jonas Emsley, Christopher E. Brightling, Ian P. Hall, Karen Affleck, Matthew Edwards, Martijn C. Nawijn, Gerard H. Koppelman, Antoon J. van Oosterhout, Ian Sayers	1
2	Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials 2024 ·Annals of the Rheumatic Diseases ·Tina Baker, (unknown), Paul J. Newcombe, Patrick G. Gavin, Mark Lazarus, Madhu Ramaswamy, Wendy I. White, Nicola Ferrari, Daniel Muthas, Raj Tummala, Eric F. Morand, Richard Furie, Edward M Vital, Chris Chamberlain, Adam Platt, Hussein Al‐Mossawi, Philip Z. Brohawn, Eszter Csomor	32
3	POS0409 IMPROVEMENTS IN CD163, A URINARY BIOMARKER OF RENAL INFLAMMATION, WITH ANIFROLUMAB: RESULTS FROM A PHASE 2 TRIAL IN LUPUS NEPHRITIS 2024 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), M. Pétri, (unknown), Eszter Csomor, Philip Z. Brohawn, Daniel Muthas, Adam Platt, Catharina Lindholm	1
4	A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale 2024 ·Clinical and Experimental Rheumatology ·Dinesh Khanna, Christopher P. Denton, Shervin Assassi, Masataka Kuwana, Yannick Allanore, Robyn T. Domsic, C. Kleoudis, John Xu, Eszter Csomor, (unknown), (unknown), Raj Tummala, Hussein Al‐Mossawi, Rubana N. Kalyani, Francesco Del Galdo	3
5	Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study 2022 ·The Lancet Rheumatology ·Kristina E N Clark, Eszter Csomor, Corrado Campochiaro, N. W. Galwey, (unknown), Mary A. Morse, Yee Voan Teo, Johannes Freudenberg, Voon H Ong, Emma Derrett‐Smith, Diego A. Wisniacki, Shaun Flint, Christopher P. Denton	7
6	Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis 2022 ·Lara D. Veeken ·Christopher P. Denton, Francesco Del Galdo, Dinesh Khanna, Madelon C Vonk, Leland W.K. Chung, Sindhu R. Johnson, John Varga, Daniel E. Furst, (unknown), Chiara Zecchin, Eszter Csomor, Amy S. Lee, Nicolas Wisniacki, Shaun Flint, Juliet Reid	20
7	Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis 2021 ·Annals of the Rheumatic Diseases ·Kristina E N Clark, Corrado Campochiaro, Eszter Csomor, Adam Taylor, (unknown), N. W. Galwey, Mary A. Morse, Jennifer S. Singh, Yee Voan Teo, Voon H Ong, Emma Derrett‐Smith, Nicolas Wisniacki, Shaun Flint, Christopher P. Denton	23
8	P154 High-density proteomic analysis of skin blister fluid and plasma in systemic sclerosis identifies local and systemic differences for key proteins 2021 ·Lara D. Veeken ·Kristina E N Clark, Corrado Campochiaro, Eszter Csomor, Adam Taylor, (unknown), Mary A. Morse, Voon H Ong, Emma Derrett‐Smith, Diego A. Wisniacki, Shaun Flint, Christopher P. Denton	1
9	Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis 2019 ·Scientific Reports ·(unknown), Benoît Roux, Eszter Csomor, Carol Feghali‐Bostwick, Lynne A. Murray, Deborah Clarke, Mark A. Lindsay	20
10	Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis 2017 ·Journal of Allergy and Clinical Immunology ·Judith L. Thijs, Ian Strickland, Carla A.F.M. Bruijnzeel-Koomen, Stefan Nierkens, Barbara Giovannone, Eszter Csomor, Bret R. Sellman, Tomas Mustelin, Matthew A. Sleeman, Marjolein de Bruin‐Weller, Athula Herath, Julia Drylewicz, Richard May, DirkJan Hijnen	119
11	Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 2009 ·Proceedings of the National Academy of Sciences ·Adel Benlahrech, Julian D. Harris, Andrea Meiser, (unknown), Julia Hornig, Peter Hayes, André Lieber, Takis Athanasopoulos, Véronique Bachy, Eszter Csomor, Rod S. Daniels, Kerry Fisher, Frances Gotch, Leonard W. Seymour, Karen Logan, (unknown), Linda S. Klavinskis, George Dickson, Steven Patterson	119
12	Complement production and regulation by dendritic cells: Molecular switches between tolerance and immunity 2008 ·Molecular Immunology ·Cees van Kooten, (unknown), Leendert A. Trouw, Eszter Csomor, Wei Xu, Giuseppe Castellano, Mohamed R. Daha, Kyra A. Gelderman	29
13	Complement protein C1q induces maturation of human dendritic cells 2007 ·Molecular Immunology ·Eszter Csomor, Zsuzsa Bajtay, Noémi Sándor, Koloman Krištof, Gérard J. Arlaud, Steffen Thiel, Anna Erdei	65
14	Expression and role of Fc- and complement-receptors on human dendritic cells 2005 ·Immunology Letters ·Zsuzsa Bajtay, Eszter Csomor, Noémi Sándor, Anna Erdei	59
15	Inhibitor of complement, Compstatin, prevents polymer‐mediated Mac‐1 up‐regulation of human neutrophils independent of biomaterial type tested 2003 ·Journal of Biomedical Materials Research Part A ·Silke Schmidt, Gerhard Haase, Eszter Csomor, Rudolf Lütticken, Heidrun Peltroche‐Llacsahuanga	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact